EX-23.2
Published on March 27, 2017
Exhibit 23.2
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the use in this Registration Statement on Form S-4 of OncoGenex Pharmaceuticals, Inc. of our report dated March 27, 2017 relating to the financial statements of Achieve Life Science, Inc. which appears in such Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP |
Chartered Professional Accountants |
Vancouver, British Columbia |
March 27, 2017 |